125 related articles for article (PubMed ID: 34962348)
1. Effluent N-terminal expressed in renal cell carcinoma/mesothelin predicts increased peritoneal permeability in patients undergoing peritoneal dialysis.
Idei M; Abe M; Tanaka M; Nakata J; Isshiki M; Hino O; Miida T
Ther Apher Dial; 2022 Oct; 26(5):1014-1022. PubMed ID: 34962348
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic lipase activity in overnight effluent predicts high transport status in peritoneal dialysis patients.
Idei M; Tabe Y; Hamada C; Miyake K; Takemura H; Io H; Wakita M; Horii T; Tomino Y; Ohsaka A; Miida T
Clin Chim Acta; 2016 Nov; 462():65-70. PubMed ID: 27531412
[TBL] [Abstract][Full Text] [Related]
3. Peritoneal dialysate effluent and serum CA125 concentrations in stable peritoneal dialysis patients.
Redahan L; Davenport A
J Nephrol; 2016 Jun; 29(3):427-434. PubMed ID: 26616639
[TBL] [Abstract][Full Text] [Related]
4. Adrenomedullin in peritoneal effluent expressed by peritoneal mesothelial cells.
Kono R; Kanozawa K; Shimosawa T; Tayama Y; Matsuda A; Hasegawa H; Mitarai T
Clin Exp Nephrol; 2014 Feb; 18(1):124-9. PubMed ID: 23564381
[TBL] [Abstract][Full Text] [Related]
5. Determinants of peritoneal solute transport rates in newly started nondiabetic peritoneal dialysis patients.
van Esch S; Zweers MM; Jansen MA; de Waart DR; van Manen JG; Krediet RT
Perit Dial Int; 2004; 24(6):554-61. PubMed ID: 15559485
[TBL] [Abstract][Full Text] [Related]
6. Dialysate cancer antigen 125 concentration as marker of peritoneal membrane status in patients treated with chronic peritoneal dialysis.
Krediet RT
Perit Dial Int; 2001; 21(6):560-7. PubMed ID: 11783764
[TBL] [Abstract][Full Text] [Related]
7. The clinical usefulness of peritoneal dialysis fluids with neutral pH and low glucose degradation product concentration: an open randomized prospective trial.
Choi HY; Kim DK; Lee TH; Moon SJ; Han SH; Lee JE; Kim BS; Park HC; Choi KH; Ha SK; Han DS; Lee HY
Perit Dial Int; 2008; 28(2):174-82. PubMed ID: 18332454
[TBL] [Abstract][Full Text] [Related]
8. Prothrombin fragment 1 + 2 (F1 + 2) in effluent is a useful marker for peritoneal permeability in peritoneal dialysis patients using neutral dialysate.
Sakurada T; Kojima S; Oishi D; Koitabashi K; Miyamoto M; Shirai S; Shibagaki Y; Yasuda T; Sato T; Kimura K
Adv Perit Dial; 2011; 27():2-5. PubMed ID: 22073819
[TBL] [Abstract][Full Text] [Related]
9. Inflammatory factors for hypoalbuminemia in Japanese peritoneal dialysis patients.
Shioya M; Yoshida T; Kasai K; Furuya R; Kato A; Mori N; Matsumoto Y; Kumagai H
Nephrology (Carlton); 2013 Aug; 18(8):539-44. PubMed ID: 23718260
[TBL] [Abstract][Full Text] [Related]
10. Expression of cancer antigen 125 by peritoneal mesothelial cells is not influenced by duration of peritoneal dialysis.
Sanusi AA; Zweers MM; Weening JJ; de Waart DR; Struijk DG; Krediet RT
Perit Dial Int; 2001; 21(5):495-500. PubMed ID: 11757834
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of effluent markers cancer antigen 125, vascular endothelial growth factor, and interleukin-6: relationship with peritoneal transport.
Rodrigues A; Martins M; Santos MJ; Fonseca I; Oliveira JC; Cabrita A; Melo e Castro J; Krediet RT
Adv Perit Dial; 2004; 20():8-12. PubMed ID: 15384786
[TBL] [Abstract][Full Text] [Related]
12. Restoration of peritoneal integrity after withdrawal of peritoneal dialysis: characteristic features of the patients at risk of encapsulating peritoneal sclerosis.
Otsuka Y; Nakayama M; Ikeda M; Sherif AM; Yokoyama K; Yamamoto H; Kawaguchi Y
Clin Exp Nephrol; 2005 Dec; 9(4):315-319. PubMed ID: 16362159
[TBL] [Abstract][Full Text] [Related]
13. Impact of combination therapy with peritoneal dialysis and hemodialysis on peritoneal function.
Moriishi M; Kawanishi H; Tsuchiya S
Adv Perit Dial; 2010; 26():67-70. PubMed ID: 21348383
[TBL] [Abstract][Full Text] [Related]
14. Effluent CA 125 concentration in chronic peritoneal dialysis patients: influence of PD duration, peritoneal transport and PD regimen.
Fusshöller A; Grabensee B; Plum J
Kidney Blood Press Res; 2003; 26(2):118-22. PubMed ID: 12771537
[TBL] [Abstract][Full Text] [Related]
15. Influence of pH-neutral peritoneal dialysis solution.
Moriishi M; Kawanishi H; Kawai T; Takahashi S; Hirai T; Shishida M; Watanabe H; Takahashi N
Adv Perit Dial; 2002; 18():68-71. PubMed ID: 12402590
[TBL] [Abstract][Full Text] [Related]
16. The association between the vascular endothelial growth factor-to-cancer antigen 125 ratio in peritoneal dialysis effluent and the epithelial-to-mesenchymal transition in continuous ambulatory peritoneal dialysis.
Do JY; Kim YL; Park JW; Chang KA; Lee SH; Ryu DH; Kim CD; Park SH; Yoon KW
Perit Dial Int; 2008 Jun; 28 Suppl 3():S101-6. PubMed ID: 18552237
[TBL] [Abstract][Full Text] [Related]
17. Impact on peritoneal membrane of use of icodextrin-based dialysis solution in peritoneal dialysis patients.
Moriishi M; Kawanishi H; Tsuchiya S
Adv Perit Dial; 2006; 22():24-8. PubMed ID: 16983933
[TBL] [Abstract][Full Text] [Related]
18. Effect of glucose degradation products on the peritoneal membrane in a chronic inflammatory infusion model of peritoneal dialysis in the rat.
Park SH; Lee EG; Kim IS; Kim YJ; Cho DK; Kim YL
Perit Dial Int; 2004; 24(2):115-22. PubMed ID: 15119632
[TBL] [Abstract][Full Text] [Related]
19. Dialysate copeptin and peritoneal transport in incident peritoneal dialysis patients.
Fijałkowski M; Safranow K; Lindholm B; Ciechanowski K; Muraszko AM; Dołęgowska B; Dołęgowska K; Golembiewska E
Int Urol Nephrol; 2019 Sep; 51(9):1667-1673. PubMed ID: 31187425
[TBL] [Abstract][Full Text] [Related]
20. Dialysate cell population and cancer antigen 125 in stable continuous ambulatory peritoneal dialysis patients: their relationship with transport parameters.
Lai KN; Lai KB; Szeto CC; Ho KK; Poon P; Lam CW; Leung JC
Am J Kidney Dis; 1997 May; 29(5):699-705. PubMed ID: 9159303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
